Prophylactic uses of fully reduced forms of hmgb1 prior to injury
The subject invention provides a method of preventing a consequence of an anticipated injury in a subject which comprises administering to the subject a therapeutically effective amount of the fully reduced (all thiol) form of HMGB1 or a biologically active truncated form of HMGB1, so as to prevent...
| Main Authors: | , , , , |
|---|---|
| Format: | Patent |
| Language: | English |
| Published: |
2019
|